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Abstract
Background: The purpose of this study was to assess the reliability and construct validity of the Spanish version of
the 6-item carpal tunnel syndrome (CTS) symptoms scale (CTS-6).
Methods: In this cross-sectional study 40 patients diagnosed with CTS based on clinical and neurophysiologic
criteria, completed the standard Spanish versions of the CTS-6 and the disabilities of the arm, shoulder and
hand (QuickDASH) scales on two occasions with a 1-week interval. Internal-consistency reliability was assessed
with the Cronbach alpha coefficient and test-retest reliability with the intraclass correlation coefficient, two way
random effect model and absolute agreement definition (ICC2,1). Cross-sectional precision was analyzed with
the Standard Error of the Measurement (SEM). Longitudinal precision for test-retest reliability coefficient was
assessed with the Standard Error of the Measurement difference (SEMdiff) and the Minimal Detectable Change
at 95 % confidence level (MDC95). For assessing construct validity it was hypothesized that the CTS-6 would
have a strong positive correlation with the QuickDASH, analyzed with the Pearson correlation coefficient (r).
Results: The standard Spanish version of the CTS-6 presented a Cronbach alpha of 0.81 with a SEM of 0.3. Test-retest
reliability showed an ICC of 0.85 with a SRMdiff of 0.36 and a MDC95 of 0.7. The correlation between CTS-6 and
the QuickDASH was concordant with the a priori formulated construct hypothesis (r 0.69)
Conclusions: The standard Spanish version of the 6-item CTS symptoms scale showed good internal consistency,
test-retest reliability and construct validity for outcomes assessment in CTS. The CTS-6 will be useful to clinicians
and researchers in Spanish speaking parts of the world. The use of standardized outcome measures across countries
also will facilitate comparison of research results in carpal tunnel syndrome.
Keywords: Carpal tunnel syndrome, CTS-6 symptoms scale, Patient-reported outcomes, Carpal tunnel release,
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Background
The use of disease-specific measures of patient-reported
outcomes (PRO) has grown in clinical research. Carpal
tunnel syndrome (CTS) is one of the most frequent condi-
tions managed at hand surgery services. The CTS ques-
tionnaire developed by Levine et al. [1] has been among
the most widely used PRO measures during the last
two decades. The CTS questionnaire consists of two
scales: symptoms severity (SS) (11 items) and functional
status (FS). Atroshi et al. [2], using factor analysis and Items
Response Theory methodology, developed a short version
of the CTS SS-scale consisting of 6 items with the purpose
of reducing respondent burden while maintaining the sca-
le's psychometric properties. They have demonstrated that
the new brief version possessed a good level of reliability,
validity and responsiveness [2–4]. Because a Spanish ver-
sion of the 11-item symptom severity scale was already
available [5], a Spanish version of the shorter version (CTS-
6) was introduced [6]. No new evidence has been reported
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about the reliability and validity of the CTS-6 since the first
description done by Atroshi et al. [2] in 2009.
The purpose of this study was to assess the reliability
and construct validity of the Spanish version of the 6-items
CTS symptoms scale for outcomes assessment in CTS.
Methods
Study population
All procedures performed in this study involving human
participants were in accordance with the ethical standards
of the institutional national research committee of the
University Hospital of La Candelaria, School of Medicine,
University of La Laguna and with the 1964 Helsinki
declaration and its later amendments or comparable eth-
ical standards. The ethic committe reviewed and approved
this study. Written informed consent was obtained from
all individual participants included in the study.
Eligibility criteria
The inclusion criteria were: (1) numbness or tingling
with or without pain in at least 2 of the 4 radial digits
[7, 8], (2) increased symptoms with carpal tunnel provoca-
tive tests (positive Phalen and/or reverse Phalen test) [8],
(3) symptoms duration of more than two months [7], (4)
failure of conservative treatment [7], and nerve conduction
test showing median neuropathy at the wrist (distal motor
latency > 4.5 milliseconds, wrist-digit sensory latency > 3.5
milliseconds, or sensory conduction velocity at the carpal
tunnel segment < 40 m/s) [9, 10]. The exclusion criteria
were clinical or electrophysiological signs of proximal
nerve compression, diabetes or other metabolic disease,
and rheumatoid arthritis or other general inflammatory
diseases [7, 8, 11].
Recruitment and enrollment
The study was conducted at a single center, orthopaedic
department, University Hospital of La Candelaria. Pa-
tients were recruited among those referred by primary
care doctors because of symptoms of CTS. Eligible pa-
tients were enrolled by the examining orthopaedic-
hand surgeons (YMH, LRM) after thorough clinical
examination and nerve conduction study. Patients who
met the eligibility criteria were scheduled for surgery and
invited to participate in the study. Each patient was given
verbal and written information about the study and in-
formed consent was obtained.
The study population consisted of 40 consecutive pa-
tients with the diagnosis the CTS and waiting for carpal
tunnel release in the National Health System, Tenerife,
Spain (Table 1).
Clinical design
A cross-sectional study which adhered to STROBE
guidelines (Additional file 1).
Outcomes measures
The standard Spanish versions of the CTS-6 [6] and the
11-item disabilities of the arm, shoulder and hand
(QuickDASH) questionnaire (www.dash.iwh.on.ca) were
completed by the patients at the outpatient clinic.
The CTS-6 measures symptoms severity related to CTS.
It consists of 6 items. Five of the 6 items in the CTS-6 have
similar item text as the corresponding items in the original
11-item symptom severity scale and the remaining item
(the result of merger of 2 symptom severity scale items)
has text from the 2 items. The CTS-6 has, however, a com-
pletely different and improved layout [2]. The scoring is
similar to that for the 11-item symptom severity scale; for
each patient the item responses are scored from 1 (best) to
5 (worst) and then averaged for the 6 items to yield a
CTS-6 score (only 1 missing item response is allowed).
The QuickDASH is the shorter version of the DASH
PRO measure [12] developed for measuring “upper ex-
tremities disability”. It consists of 11 items and it is
scored from 0 (best) to 100 (worst). At least 10 of the 11
items must be completed for a score to be calculated.
Each item is scored 1 to 5 and the assigned values for all
completed items are summed and averaged, producing a
score of 1 to 5. This value is then transformed to a score
of 0 to 100 by subtracting one and multiplying by 25.
This transformation is done to make the score easier to
compare to other measures scaled on a 0–100 scale.
No missing items from the two PRO instruments were
observed in this study.
For assessing test-retest reliability a second self ad-
ministration of the CTS-6 was done at the clinic 1 week
after the first administration.
Data analysis
Internal-consistency reliability was assessed with the
Cronbach alpha coefficient (alpha > 0.7 indicates good in-
ternal consistency). Test-retest reliability was assessed
with the intraclass correlation coefficient, two way random
effect model and absolute agreement definition (ICC2,1)
and by comparing the mean CTS-6 scores for the two
consecutive administrations with the paired t-test. For the
Table 1 Patients and demographic characteristics
Study Population (N = 40)
Age (mean, SD) 54 (11)
Gender (male/female) 14/26
Affected Hand (right/left) 27/13
Baseline CTS-6 scorea (mean, SD) 3.7 (0.7)
Baseline QucikDASH scoreb (mean, SD) 63.9 (19.5)
aCTS-6 (symptoms severity) range of scores from 1 (no symptoms) to 5 (most
severe symptoms)
bQuickDASH (upper extremity disability) range of scores from 0 (no disability)
to 100 (most severe disability)
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test-retest reliability mean difference analysis, a sample of
19 individiuals will be needed to detect an important clin-
ical difference of 0.9 in the CTS-6 scores, assuming a SD
of 0.7 [2], two-sided test, power of 80 %, and a level of sig-
nificance of 0.05. Cross- sectional precision was analyzed
based on the Standard Error of the Measurement (SEM).
Longitudinal precision for test-retest reliability coefficient
was assessed with the Standard Error of the Measurement
difference (SEMdiff) and the Minimal Detectable Change
at 95 % confidence level (MDC95). For assessing construct
validity it was hypothesized that the CTS-6 scores would
have a moderate to strong positive correlation with the
QuickDASH. The construct validity hypothesis was ana-
lyzed with the Pearson correlation coefficient (r), using a
level 0.01 for statistical significance (values between 0. 8
and 1.0 indicating a very strong relationship, between 0.6
and 0.8 a strong relationship, between 0.4 and 0.6 a mod-
erate relationship, between 0.2 and 0.4 a weak relation-
ship, and less than 0.2 very weak or no relationship) [13].
All parametric tests used in the analysis was based on the




The Cronbach alpha coefficient was 0.81 with SEM of 0.3,
and the ICC was 0.85 (p < 0.001) with SRMdiff of 0.36 and
a MDC95 of 0.7. The mean difference in the CTS-6 scores
for the two administration times was 0.09 (95 % confi-
dence interval −0.07 to 0.26, p = 0.27) (Table 2).
Construct validity
There was a strong positive correlation between the scores
for the CTS-6 scale and the QuickDASH (r = 0.69, p
< 0.001),
Discussion
The results have demonstrated that the CTS-6 PRO
measure has good internal consistency and test-retest re-
liability with a mean difference of the 1-week test-retest
scores not statistically different from zero and lower
than the MDC95. A high level of intraclass correlation
that meets the minimal standards for reliability ana-
lysis was observed. Besides, the correlations were con-
cordant with the construct hypothesis formulated a
priori, supporting construct validity.
One of the measurement properties of PRO instruments
included by the Medical Outcomes Trust in the instru-
ments review criteria is the “respondent burden" defined
as the time, energy, and other demands placed on those to
whom the instrument is administered [14]. The CTS-6
was developed to improve patient acceptance, to increase
response rate and consequently the efficiency of the scale
while maintaining good psychometric properties [3].
In this study, the Spanish CTS-6 presented a Cron-
bach alpha coefficient of 0.81 and an ICC of 0.85. Simi-
lar results have been reported with the original CTS-6
(Cronbach alpha = 0.86, ICC = 0.95) [2]. The mean dif-
ference of scores in two administration times in the ori-
ginal CTS-6 was 0.03 (95 % CI −0.07 to 0.12) [2]. In the
present study the mean difference in the test-retest
scores was 0.09 (95 % CI −0.07 to 0.26), lower than the
MDC95. (0.7). The test-retest reliability results are simi-
lar to the reliability of the longer Spanish version (11-
items symptom severity scale), with the same “washout
time” of 1 week (mean difference in scores = 0.18, 95 %
CI −0.16 to 0.53, p = 0.248) [5]. Consequently, the Span-
ish CTS-6 presents a level of reliability similar to the
original CTS-6 and the Spanish CTS-11.
There are different aspects of validity of a health out-
come measure: content validity, criterion-validity, and con-
struct validity [14–16]. Common methods to assess
construct-related validity include examination of the
logical relationship that should exist between that measure
and other measures and/or patterns of scores across
groups of individuals. Testing for construct validity in-
volves assessing both theory and method simultaneously.
Therefore, it should include the hypothesis that can
demonstrate the proposed construct (theory) [15, 16].
Many factors should be considered when choosing hy-
potheses. The most important factor is the specific di-
mension of health or concept that is intended to be
Table 2 Results of the CTS-6 Reliability Analysis (N = 40)
Internal consistency. Calculated SEM and cross-sectional precision estimates for CTS-6 scores using Cronbach alpha coefficient and SD observed
during field testing
Cronbach alpha coefficient SD of CTS-6 scores SEM Range of cross-sectional precision of CTS-6 scores 95 % confidence level
0.81 0.68 0.3 Observed score +/−0.59
Test-retest reproducibility. Calculated longitudinal SEM of differences (SEM diff) based on test-retest reliability coefficient (ICC2,1) and the SD of baseline
scores
Mean difference score (95 % CI)a ICC(2,1) (95 % CI)
a SEMdiff MDC (95)
0.09 (−0.07–0.26) 0.85 (0.71–0.92) 0.36 0.70
ICC (2,1) Intraclass correlation coefficient: two-way random effect model (absolute agreement definition), MDC (95) minimal detectable change 95 % CI
aMean difference between scores recorded in 2 successive administration times 1 week apart. CI = confidence interval
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measured by using a patient-completed questionnaire
and the way or direction of scoring of every instrument
studied. Atroshi et al. [2] demonstrated a convergent
validity by a strong correlation between the original
CTS-6 scores and the QuickDASH scores (r = 0.7). In
this study we have observered a very similar correlation
coefficient (r = 0.69) between the Spanish CTS-6 and
QuickDASH. The results of this study showed that the
prespecified construct hypothesis was established.
We did not perform a priori sample size calculation
for the correlation analysis and it may be a limitation of
this study. However, post hoc analysis has shown that
based on the proposed null hypothesis (Ho = the correla-
tions is equal zero), with a level of significance of 0.01,
two-tailed test and the observed correlation coefficient
of 0.69, a sample size of 20 patients would have a power
of 80 % to yield a statistically significant result [17].
Measurement Error Statistics (MES) can help clinicians
and researchers decide on a best practice whether the ob-
served scores or change in a patient´s performance is true.
But, MES does not provide information about which min-
imal change in CTS-6 scores is related to an important
clinical improvement for the patients, called as “Minimal
Clinically Importance Difference (MICD)”. Consequently,
further studies regarding responsiveness and MCID are
recommended to complete the analysis of the measure-
ments properties of the Spanish CTS-6.
Conclusions
This study demonstrates that the Spanish CTS-6 has good
reliability and construct validity for outcomes assessment
in CTS. The CTS-6 will be useful to clinicians and re-
searchers in Spanish speaking parts of the world. The use
of standardized outcome measures across countries also
will facilitate comparison of research results in carpal
tunnel syndrome.
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